Tag Archives: Phenomics

Tissue Phenomics for Biomarker Identification in Active Immuno-Oncology Therapy

To date, the search for biomarkers to best guide active immunologic therapy selection and monitoring of response has not been fruitful. Unlike molecular targeted therapies and monoclonal antibodies for which the presence of mutated or over-expressed proteins (e.g., Philadelphia Chromosome, B-raf, HER-2, and CD20) is a prerequisite to use, Continue reading